Table 2.
Ongoing lenalidomide (L) monotherapy trials.
Name | Phase | Age | Histology | Drugs | Status |
---|---|---|---|---|---|
NCT00875667 | II | >18 ys | Relapsed or refractory MCL | L | Ongoing and recruiting |
NCT00737529 | II | >18 ys | Relapsed or refractory MCL | L | Ongoing and recruiting |
NCT00179673 | II | >18 ys | Relapsed or refractory indolent NHL | L | Terminated |
L: lenalidomide.